Richard N Rosenthal, M.D.
Arthur J. Antenucci Professor of Clinical Psychiatry
Chairman, Department of Psychiatry,
St. Luke's Roosevelt Hospital Center, NY
Senior Associate Dean for the St. Luke's Roosevelt Hospital Affiliation,
Dr. Rosenthal is Chairman of Psychiatry at St. Luke's-Roosevelt Hospital Center, NY, a major teaching hospital of Columbia University. He is also Past President of the American Academy of Addiction Psychiatry (aaap.org), a Distinguished Fellow of the American Psychiatric Association and a Fellow of the New York Academy of Medicine.
He is a diplomate of the American Board of Psychiatry and Neurology in psychiatry, with subspecialty certification in addiction psychiatry. Prior to coming to St. Luke's-Roosevelt, he was associate chairman for psychiatric clinical services of Beth Israel Medical Center, NY (BIMC) and directed the division on substance abuse at Albert Einstein College of Medicine.
Dr. Rosenthal's main research focus has been on the evaluation and treatment of the severely mentally ill with co-occurring addictive disorders, and he has been a clinical, research, and program development consultant to hospitals, state and federal agencies, and the pharmaceutical industry.
Following residency training, he served as Division Chief of the Substance Abuse Service (Psychiatry) at BIMC. During this time, he created the Combined Psychiatric and Addictive Disorders treatment research program, and co-developed and manualized Brief Supportive Psychotherapy for the Brief Psychotherapy Research Program.
Dr. Rosenthal also has a long-term interest in medical informatics and is president of the American Association for Technology in Psychiatry (techpsych.org), as well as Chair of the Information Systems Review Committee of the New York State Hospital Planning and Review Council. He has developed systems to screen behavioral health patients and track treatment response using interactive voice response (IVR).
In 2004, Governor Pataki appointed Dr. Rosenthal to the NY State Mental Health Services Council. He was also appointed in 2004 as Senior Fellow, SAMHSA Co-Occurring Disorders Center for Excellence and Co-Chairman of its National Steering Council (coce.samhsa.gov). He maintains a private practice of psychotherapy and psychopharmacology for mood and addictive disorders.
Undergraduate: Oberlin College, BA, 1970-1973
Graduate: Duke University, MA, 1974-1977
Medical School: SUNY Downstate Medical Center, MD, 1976-1980
Internship: Mount Sinai Hospital, 1980- 1981
Residency: Mount Sinai Hospital, 1981-1984
Board Certifications: American Board of Psychiatry and Neurology
Subspeciality Certifications: Addiction Psychiatry
• Addiction Psychiatry
• Mood disorders
• Short-term Dynamic Psychotherapy
1090 Amsterdam Ave
New York, NY 10025
1. Miner CR, Rosenthal RN, Hellerstein DJ : Prediction of non-compliance with outpatient treatment referral in substance-abusing schizophrenics. Arch Gen Psych 1997;54: 706-699
2. Rosenthal RN, Perkel C, Singh P, Anand O, Miner C: A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal. American Journal on Addictions 1998;7: 189-197
3. Kranzler HR, Rosenthal RN: Dual diagnosis: Alcoholism and co-morbid psychiatric disorders. American Journal on Addictions 2003;12[suppl 1]: S26-40
4. Winston A, Rosenthal RN, Pinsker H : Introduction to Supportive Psychotherapy, American Psychiatric Publishing, Inc, Washington, DC, 2004
5. Rosenthal RN, Gage A, Perhach JL, Goodman AM: Acamprosate: safety and tolerability in the treatment of alcohol dependence. Journal of Addiction Medicine 2008;2: 40-50